The post-closing trial balance of Tamarisk, Inc. at December 31, 2022, contains the following stockholders' equity accounts. Preferred Stock (14,300 shares issued) Common Stock (249,000 shares issued) Paid-in Capital in Excess of Par-Preferred Stock Paid-in Capital in Excess of Par-Common Stock Common Stock Dividends Distributable Retained Earnings $715,000 3,735,000 249,000 396,000 373,500 817,350 A review of the accounting records reveals the following. 1. 2. 3. 4. 5. 6. No errors have been made in recording 2022 transactions or in preparing the closing entry for net income. Preferred stock is $50 par, 6%, and cumulative; 14,300 shares have been outstanding since January 1, 2021. Authorized stock is 19,300 shares of preferred, 498,000 shares of common with a $15 par value. The January 1 balance in Retained Earnings was $1,120,000. On July 1, 19,000 shares of common stock were issued for cash at $18 per share. On September 1, the company discovered an understatement error of $88,000 in computing depreciation in 2019, which overstated net income. The net of tax effect of $61,600 was properly debited directly to Retained Earnings. A cash dividend of $373,500 was declared and properly allocated to preferred and common stock on October 1. No dividends were paid to preferred stockholders in 2021. On December 31, a 10% common stock dividend was declared out of retained earnings on common stock when the market price per share was $18. Net income for the year was $580,650. On December 31, 2022, the directors authorized disclosure of a $190,000 restriction of retained earnings for plant 7. 8. 9. 10. (a) Reproduce the Retained Earnings account (T-account) for 2022. (List items in order presented in the problem.) Retained Earnings